GB0313625D0 - Therapeutic and assay methods - Google Patents
Therapeutic and assay methodsInfo
- Publication number
- GB0313625D0 GB0313625D0 GB0313625A GB0313625A GB0313625D0 GB 0313625 D0 GB0313625 D0 GB 0313625D0 GB 0313625 A GB0313625 A GB 0313625A GB 0313625 A GB0313625 A GB 0313625A GB 0313625 D0 GB0313625 D0 GB 0313625D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic
- assay methods
- assay
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0313625A GB0313625D0 (en) | 2003-06-12 | 2003-06-12 | Therapeutic and assay methods |
JP2006500600A JP2006518995A (en) | 2003-01-17 | 2004-01-16 | Modulation of deubiquitinase family members |
EP04702705A EP1583971A2 (en) | 2003-01-17 | 2004-01-16 | Modulation of deubiquitinase family members |
CA002513470A CA2513470A1 (en) | 2003-01-17 | 2004-01-16 | Modulation of deubiquitinase family members |
AU2004206736A AU2004206736A1 (en) | 2003-01-17 | 2004-01-16 | Modulation of deubiquitinase family members |
US10/542,024 US20060105344A1 (en) | 2003-01-17 | 2004-01-16 | Modulation of deubiquitinase family members |
PCT/EP2004/000408 WO2004064711A2 (en) | 2003-01-17 | 2004-01-16 | Modulation of deubiquitinase family members |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0313625A GB0313625D0 (en) | 2003-06-12 | 2003-06-12 | Therapeutic and assay methods |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0313625D0 true GB0313625D0 (en) | 2003-07-16 |
Family
ID=27589985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0313625A Ceased GB0313625D0 (en) | 2003-01-17 | 2003-06-12 | Therapeutic and assay methods |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB0313625D0 (en) |
-
2003
- 2003-06-12 GB GB0313625A patent/GB0313625D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200603882B (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides | |
EP1679966A4 (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides | |
GB0307918D0 (en) | Therapeutic use | |
HK1084883A1 (en) | 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof | |
EP1638977A4 (en) | Salinosporamides and methods for use thereof | |
EP1682136A4 (en) | Therapeutic compounds and uses thereof | |
HK1088837A1 (en) | Clk-peptide and slk-peptide | |
EP1838288A4 (en) | Therapeutic materials and methods | |
IL172704A0 (en) | Salinosporamides and methods for use thereof | |
GB0428391D0 (en) | Connection and connection part | |
GB0303663D0 (en) | Assays and medical treatments | |
GB0308382D0 (en) | Therapeutic methods and means | |
HK1094531A1 (en) | P185neu-encoding dna and therapeutical uses thereof | |
GB0407382D0 (en) | Therapeutic methods and means | |
GB0318546D0 (en) | Quinoxalinones and their use | |
GB2400659B8 (en) | Assay methods and materials | |
EP1701736A4 (en) | Therapeutic agents and uses therefor | |
EP1569928A4 (en) | Therapeutic compounds and methods | |
EP1487547A4 (en) | Physical interaction means and related uses thereof | |
GB0313625D0 (en) | Therapeutic and assay methods | |
GB0223960D0 (en) | Assay methods | |
AU2003231937A8 (en) | Therapeutic methods | |
GB0327844D0 (en) | Therapeutic methods and means | |
GB0202565D0 (en) | Assay methods and means | |
GB0216754D0 (en) | Therapeutic methods and means |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |